Striking increase of thin melanomas contrasts with stable incidence of thick melanomas.

OBJECTIVE The aim of this study was to analyze the temporal evolution of melanoma incidence in the department of the Bas-Rhin, France, and to study the evolution of tumor thickness. DESIGN Retrospective study including all histologically proven melanomas recorded at the cancer registry of the department of the Bas-Rhin between January 1980 and December 1992 and at the Cutaneous Histopathology Department of the University Hospitals, Strasbourg, between January 1980 and December 1997. SETTING Population-based cancer registry and academic cutaneous histopathology department. PATIENTS A total of 1254 patients with histologically proven melanomas. INTERVENTION None. MAIN OUTCOME MEASURES Temporal evolution of melanoma incidence and tumor thickness. RESULTS The mean (SD) and median tumor thicknesses were 1.48 (1.59) mm and 0.87 mm, respectively, and they decreased during the study period. The increase in the number of melanomas was mainly related to an increase of superficial spreading melanomas in both sexes. The number of intermediate melanomas (1-2 mm) in both sexes and the number of melanomas with a Breslow index between 2 and 4 mm in women increased only slightly. The number of melanomas with a Breslow index greater than 2 mm in men and greater than 4 mm in women remained stable during the reference period. CONCLUSION A striking increase in incidence of thin melanomas contrasts with a stable incidence of thick melanomas.

[1]  F. Langmark,et al.  Cutaneous malignant melanoma. Correlation between tumorcharacteristics and diagnostic delay in Norwegian patients , 2000 .

[2]  D. Lipsker,et al.  [Melanoma in the Strasbourg University Hospital. A 30-year study]. , 1998, Annales de dermatologie et de venereologie.

[3]  J. Hunter,et al.  Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94 , 1997, BMJ.

[4]  M. Souques,et al.  Prospective study of the incidence of melanoma in the Paris region in 1994 , 1997 .

[5]  M. Souques,et al.  Prospective study of the incidence of melanoma in the Paris region in 1994. The PETRI Melanoma Group. , 1997, Melanoma research.

[6]  J. Hunter,et al.  Incidence, mortality and survival in cutaneous malignant melanoma in Scotland 1979???1994: 260 , 1997 .

[7]  M. Ross,et al.  Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Petres,et al.  Epidemiologie des malignen Melanoms in Stadt- und Landbevölkerung , 1997 .

[9]  R. Swerlick,et al.  The melanoma epidemic. Is increased surveillance the solution or the problem? , 1996, Archives of dermatology.

[10]  D. Rigel,et al.  Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. , 1996, Journal of the American Academy of Dermatology.

[11]  R. Kerbel,et al.  Analysis and significance of the malignant 'eclipse' during the progression of primary cutaneous human melanomas. , 1996, The journal of investigative dermatology. Symposium proceedings.

[12]  P. Little,et al.  Screening for melanoma , 1995, British medical journal.

[13]  U. Chetty,et al.  Cutaneous malignant melanoma. Publicity, screening clinics and survival—the Edinburgh experience 1982–90 , 1995, The British journal of dermatology.

[14]  R. MacKie,et al.  Melanoma prevention and early detection. , 1995, British medical bulletin.

[15]  R. Burton,et al.  Recent incidence trends imply a nonmetastasizing form of invasive melanoma , 1994, Melanoma research.

[16]  D. Elder,et al.  Lessons from tumor progression: the invasive radial growth phase of melanoma is common, incapable of metastasis, and indolent. , 1993, The Journal of investigative dermatology.

[17]  M. Cristofolini,et al.  Analysis of the cost‐effectiveness ratio of the health campaign for the early diagnosis of cutaneous melanoma in Trentino, Italy , 1993, Cancer.

[18]  H. Thiele,et al.  Das maligne Melanom (MM) : Klinische und diagnostische Erfahrungen , 1993 .

[19]  N. Martin,et al.  Increasing incidence of cutaneous melanoma in Queensland, Australia. , 1992, Journal of the National Cancer Institute.

[20]  R. MacKie,et al.  Audit of public education campaign to encourage earlier detection of malignant melanoma. , 1992, BMJ.

[21]  L. Kiemeney,et al.  Melanoma/skin cancer screening clinics: experiences in The Netherlands. , 1991, Journal of the American Academy of Dermatology.

[22]  M. P. Dunkley,et al.  Cutaneous malignant melanoma: audit of the diagnostic process. , 1991, Annals of the Royal College of Surgeons of England.

[23]  J. Nectoux,et al.  Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely , 1991, International journal of cancer.

[24]  A. Laplanche,et al.  [Estimation of cancer incidence in France]. , 1991, Bulletin du cancer.

[25]  R. MacKie,et al.  Experience of a public education programme on early detection of cutaneous malignant melanoma. , 1988, BMJ.

[26]  V I Kustov,et al.  [Epidemiology of malignant melanoma]. , 1987, Voprosy onkologii.